JUNCTION THERAPEUTICS
Using the research developed from the laboratory by Matthew Campbell, Trinity College Dublin, we have developed unique technologies for controlled modulation of permeability at the blood brain barrier. Having the potential to revolutionise the treatment of neurological conditions allowing small molecules to enter the brain as treatment as well as allowing pathological molecules to be removed
